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Abstract
Background Acute otitis media (AOM) is a common self-
limiting infection where antibiotics confer limited benefit. 
Other treatments, such as anti-inflammatory agents have 
been proposed as an alternative to antibiotics, but no high-
quality clinical trials have tested this. 
Objective To identify current AOM management practices 
among Indonesian clinicians. We also required this infor-
mation for our proposed corticosteroids clinical trial for 
AOM. 
Methods This cross-sectional study surveyed a convenience 
sample of general practitioners (GPs), pediatricians, and 
Ear-Nose-Throat (ENT) specialists in Jakarta, Depok, and 
Bekasi. We addressed their current AOM management 
practices and willingness to participate in a future trial on 
corticosteroids.
Results We distributed 2,694 questionnaires through confer-
ences, primary care/hospital visits, and by mail-list group. Of 
492 questionnaires received (response rate 18%), 352 were 
from eligible clinicians. Most clinicians diagnosed AOM by 
using an otoscope (64-91%). Tympanometry was used by 
a quarter of ENT specialists. Amoxicillin-clavulanate was 
the most common antibiotic for AOM, prescribed by pe-
diatricians and ENT specialists, whilst most GPs prescribed 
amoxicillin. Clinical scenarios indicated most ENT specialists 
(88%) would prescribe antibiotics and most pediatricians 
(54%) would choose expectant observation by withholding 
antibiotics for mild AOM. Almost half of clinicians would 
consider using corticosteroids in a trial.
Conclusion Most clinicians would prescribe antibiotics for 
mild AOM. However, slightly over half of pediatricians would 
solely choose expectant observation. Adequate numbers of 
potential participating clinicians, who would consider using 
corticosteroids, make our proposed corticosteroids trial for 
AOM feasible. We found gaps between clinical practice and 
evidence requiring further investigation to improve AOM 
management in Indonesia.  [Paediatr Indones. 2019;59:303-
12; doi: http://dx.doi.org/10.14238/pi59.6.2019.303-12 ].
Antibiotics are commonly used for treating infectious diseases, including acute otitis media (AOM) in children.1,2 International guidelines recommend 
expectant observation for mild AOM, with antibiotics 
only given for severe cases.3,4 Although antibiotics are 
effective for AOM, their effects in improving pain and 
middle ear effusion are weak, they have potentially 
harmful side effects, and may lead to antibiotic 
resistance.5,6 Currently, there are two conflicting 
Indonesian guidelines for AOM. One recommends 
antibiotics for both mild and severe AOM, while 
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the other recommends antibiotics only for severe 
cases (although ‘severe’ is not clearly defined).7,8 
This potentially contributes to high use of antibiotics 
in the management of AOM in Indonesia, thereby 
increasing the risk of antibiotic resistance and other 
side effects.5,9,10 Finding alternative treatment options 
could be one way to mitigate the risk of antibiotic 
resistance. Theoretical considerations suggest that 
the anti-inflammatory effect of corticosteroids might 
reduce symptoms.1 Conflicting evidence on the 
potential benefits requires a large randomized placebo-
controlled trial (RCT) to test efficacy.12,13 We plan 
to undertake a large RCT in Indonesia to further 
investigate this issue.
To date, there is no available data on the 
current AOM management for children in Indonesia. 
However, there have been several studies surveying 
the management of AOM in other countries.14-16 A 
survey study in Turkey showed pediatricians were 
likely to prescribe antibiotics (60%) and analgesics 
(e.g., acetaminophen, ibuprofen) for children with 
AOM.14 Surveys in India and Israel showed most ENT 
specialists prescribed antibiotics for AOM (62-98%). 
Analgesics and decongestants and/or antihistamines 
were also commonly prescribed. Most ENT specialists 
in India used an otoscope as a diagnostic tool for 
AOM, whilst a microscope was more preferable in 
Israel.15,16 
We identified the current management, 
particularly with regards to prescribing antibiotics for 
AOM in three cities in Indonesia. This survey study 
was done to help us identify existing gaps between 
clinical practice and evidence in the management of 
AOM in Indonesia.  Our survey was also designed to 
gauge clinicians’ willingness to use corticosteroids in 
a future, randomized trial.
Methods
This study primarily aimed to identify the current 
management of AOM among clinicians. It also 
identified the feasibility of a proposed clinical trial 
to test corticosteroids for AOM in children. We 
conducted a cross-sectional study for our survey 
(April - August 2016). Our eligibility criteria were 
clinicians from three specialties (general practitioners, 
pediatricians, and ENT specialists) working in 
primary/secondary or tertiary healthcare facilities in 
Jakarta, Depok, and Bekasi, Indonesia. We established 
clinicians’ specialties and email addresses from 
the national professional organizations of general 
practitioners (Indonesian Medical Association), 
pediatricians (Indonesian Pediatric Society), and ENT 
specialists (Indonesian Otorhinolaryngology Head and 
Neck Surgery Society). We then distributed paper-
based questionnaires through workshops, conferences, 
primary healthcare and hospital visits. We also 
distributed electronic-based questionnaires through 
mailing lists of primary care clinician graduates from 
two medical schools in Jakarta (Universitas Indonesia 
and Universitas Pembangunan Nasional Veteran), 
identified by alumni and colleagues. 
We invited participation in a 10-minute 
presentation at the following workshops and 
conferences: (i) The Indonesian National Committee 
for the Prevention and Management of Hearing 
Impairment and Deafness Meeting (20 May 2016), 
(ii) The Continuing Professional Development 
Program: The Comprehensive Management of 
Vestibulocochlear Disorders (20-21 May 2016), (iii) 
The Third Neurotology Update Management: Hearing 
and Vestibular Disorders in Children (21 May 2016), 
(iv) The Annual Scientific Meeting of the Indonesian 
Medical Association (27-29 May 2016), and (vi) The 
Second Jakarta Pediatric Respiratory Forum (29-30 
May 2016). We distributed the questionnaires at the 
registration table on the first day of the workshops or 
conferences and collected the questionnaires at the 
end of the events. 
We identified several primary healthcare clinics 
and hospitals located in Jakarta, Depok, and Bekasi 
that were conveniently accessible. We contacted the 
heads or directors of the appointed healthcare facilities 
and distributed the questionnaires to the emergency, 
pediatric, and otorhinolaryngology departments. We 
collected the questionnaires at most 4 weeks after 
their distribution, unless completed earlier. 
Consenting clinicians typically completed the 
questionnaires in 10-20 minutes (Appendix 1). It 
had 3 sections: 1) current management of AOM 
in children, including diagnostic treatment items; 
2) 3 clinical scenarios [(a.) a child aged < 2 years 
with mild AOM; (b.) a child aged ≥ 2 years with 
mild AOM; and (c.) an older child with recurrent and 
bilateral AOM] in which respondents were invited 
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to describe their management (Table 1); and 3) a 
feasibility survey to identify the number of pediatric 
AOM patients and clinicians who might be willing to 
participate in our clinical trial on corticosteroids as 
an alternative treatment for AOM. 
We did not formally determine a sample size 
estimate. We used convenience sampling based on 
ease of accessibility to the healthcare facilities and 
clinicians who attended workshops and conferences 
specifically for general practitioners, pediatricians, and 
ENT specialists. The results of this study are reported 
as the percentage of clinicians in each category of 
responses. We used Chi-square test to identify the 
Table 1. Clinical scenarios and their interpretation
Clinical scenarios Interpretation/diagnosis Treatment recommendation3
Clinical scenario 1:
“A one-year old boy, accompanied by 
his mother, came to your practice with a 
complaint of pain in his left ear for one day. 
The pain was not severe. He has had a cold 
for the last two days with a mild fever. At the 
physical examination, he looked well and 
alert with temperature 37.8°C. At his ear, 
nose, and throat examination, there was 
mucous discharge on the nasal cavities, 
and his throat looked normal. An otoscopic 
examination showed redness and bulging 
tympanic membrane of the left ear.”
A young child (aged < 2 years) with mild 
AOM
Expectant observation (begin antibiotics if 
child worsens or fails to improve within 48 
to 72 hours of AOM onset) OR antibiotic 
therapy if close observation and follow-up 
cannot be ensured.
Clinical scenario 2:
“A four-year old girl, accompanied by her 
parents, came to your practice with a 
complaint of pain in her right ear for one day. 
She has had a cold for the last four days. She 
had no fever. At the physical examination, 
the patient looked well and alert. At her 
ear, nose, and throat examination, there 
was serous secretion in the nasal cavities 
and her throat looked normal. An otoscopic 
examination showed redness and bulging 
tympanic membrane of the right ear.”
An older child (aged ≥ 2 years) with mild 
AOM
Expectant observation (begin antibiotics if 
child worsens or fails to improve within 48 
to 72 hours of AOM onset) OR antibiotic 
therapy if close observation and follow-up 
cannot be ensured. 
Clinical scenario 3:
“A five-year old girl, accompanied by her 
parents, came to your practice with a 
complaint of pain in her right ear for one day, 
followed by left ear this morning and she had 
a mild fever. She had experienced acute 
otitis media in her right ear one month ago. At 
the physical examination, the patient looked 
well and alert with temperature 36.8°C. At 
her ear, nose, and throat examination, there 
was minimal serous discharge in her nasal 
cavities and her throat looked normal. An 
otoscopic examination showed redness and 
bulging on both tympanic membranes.”
An older child with recurrent bilateral AOM Expectant observation (begin antibiotics if 
child worsens or fails to improve within 48 
to 72 hours of AOM onset) OR antibiotic 
therapy if close observation and follow-up 
cannot be ensured. However, this guideline 
does not specify the need of antibiotics for 
recurrent AOM. 
differences between specialty groups using IBM SPSS 
Statistics 23 software. All proportions are expressed 
from respondents who answered that question in the 
questionnaires.
This study protocol was reviewed and approved 
by the Ethics Committee of the Universitas Indonesia 
Medical School and Bond University Human 
Research Ethics Committee. We provided a paper- and 
electronic-based information sheet and consent form 
to all respondents. Consent was received in written 
form and the consent process was free of coercion. 
All information obtained from the respondents was 
treated as confidential.
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Results
Of 2,694 questionnaires distributed, 492 were 
returned (response rate 18%). Of these, 445 (90%) 
participated in the survey, Figure 1. There were 352 
clinicians who responded (general practitioners 81%, 
pediatricians 10%, and ENT specialists 9%) and they 
were based at primary/secondary (44%) and tertiary 
healthcare (54%) facilities (no response 2%) in 
Jakarta (82%), Depok (10%), and Bekasi (8%), our 
target regions. Most were young, <31 years (44%), 
and female (67%).
A total of 705 children with AOM visited 
352 clinicians over a period of seven days prior to 
answering the questionnaire. Most clinicians had less 
than three AOM cases during this period (75%), and 
most of these children were between two and five years 
of age. ENT specialists had more AOM cases (three to 
five cases) per week compared to general practitioners 
and pediatricians. 
Most clinicians diagnosed AOM by using an 
otoscope (64-91%) (Table 2). Three quarters of 
ENT specialists and 9% of general practitioners 
used an endoscope. Pediatricians did not use an 
endoscope. A quarter of ENT specialists, but very 
few pediatricians (3%) or general practitioners (1%), 
used tympanometry to identify middle ear effusion. 
Few clinicians (0-6%) used a pneumatic otoscope, 
audiometry (0-9%), or tympanocentesis (0-3%) to 
diagnose AOM.
Amoxicillin-clavulanate was the most common 
antibiotic prescribed by ENT specialists (58%), 
pediatricians (46%), and general practitioners (16%) 
(Table 2). Amoxicillin was the second most common 
antibiotic prescribed by general practitioners (43%) 
and pediatricians (37%), whilst ENT specialists 
prescribed cefixime as the second common antibiotics 
for AOM (23%). Azithromycin (0-13%), cefadroxil 
(0-9%), erythromycin (3%), ampicillin (0-3%), 
and cotrimoxazole (0-3%) were the least common 
antibiotics prescribed for AOM. General practitioners 
(66%) mostly prescribed amoxicillin for three to five 
days, whilst ENT specialists (56%) and pediatricians 
(54%) prescribed amoxicillin-clavulanate for more 
than five days.
The clinicians’ treatment choices for the three 
clinical scenarios are shown in Table 3.  In the first 
scenario, 88% of ENT specialists would prescribe 
antibiotics for AOM, followed by general practitioners 
(71%) and pediatricians (57%). More ENT specialists 
Figure 1. A flow diagram of study recruitment
Seminars & workshops 
(n=1,225)
Mail-list groups
(n=600)
Healthcare facilities
(n=869)
2,694 questionnaires distributed
352 respondents were eligible 
(based in Jakarta, Depok, Bekasi) 
492 respondents returned the questionnaires
445 respondents gave their consent  
and completed the questionnaires
2,202 did not return 
the questionnaires
47 respondents did not 
give their consent
93 respondents were excluded 
(not based in Jakarta, Depok, Bekasi)
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Table 2. The common diagnostic tools and type of antibiotic prescribed among clinical specialties
Management General practitioners* (Total=284), 
n(%)
ENT specialists (Total=32),  
n (%)
Pediatricians (Total=35),
n(%)
Diagnostic examination
Otoscope 
Penlight/headlamp
Endoscope
Tympanometry
Tuning fork
Pneumatic otoscope
Tympanocentesis
Audiometry
183 (64)
159 (56)
25 (9)
  2 (1)
10 (4)
  8 (3)
  1 (1)
  4 (1)
29 (91)
  9 (28)
24 (75)
  8 (25)
  4 (13)
0 (0)
3 (9)
1 (3)
24 (69)
20 (57)
0 (0)
1 (3)
0 (0)
2 (6)
0 (0)
0 (0)
Type of antibiotics**
Amoxicillin-clavulanate
Amoxicillin
Cefixime
Azithromycin
Cefadroxil
Erythromycin
Ampicillin
Cotrimoxazole 
Others
More than one
 46 (16)
122 (43)
34 (12)
4 (1)
                      26 (9)
9 (3)
4 (1)
8 (3)
6 (2)
22 (8)†
18 (58)
0 (0)
  7 (23)
  4 (13)
0 (0)
1 (3)
0 (0)
0 (0)
0 (0)
  1 (3)‡
16 (46)
13 (37)
2 (6)
0 (0)
0 (0)
1 (3)
1 (3)
0 (0)
0 (0)
  2 (6)§
*One missing data in general practitioner group 
**Total 281 general practitioners and 31 ENT specialists provided their options of antibiotic types for AOM
†General practitioners chose amoxicillin (77%, 17/22), followed by cefixime (32%, 6/22) and cefadroxil (32%, 6/22) in the multiple antibiotic 
prescription group.
‡ENT specialist did not mention any antibiotic by name but only reported ‘depends on the condition’.
§Pediatricians chose cefixime (100%, 2/2), followed by amoxicillin (50%, 1/2) and amoxicillin-clavulanate (50%, 1/2) in the multiple antibiotic 
prescription group.  
Table 3. Treatment options for three clinical scenarios among all specialties
Treatment options
Scenario 1 
A young child (aged < 2 years) with mild AOM, 
n(%)
Scenario 2 
An older child (aged ≥ 2 years) with mild AOM, 
n(%)
Scenario 3 
An older child with recurrent bilateral AOM,  
n(%)
GP
(n=283)
ENT 
(n=32)
PED
(n=35)
Overall
(n=350)
GP
(n=280)
ENT 
(n=32)
PED
(n=35)
Overall
(n=347)
GP
(n=279)
ENT 
(n=32)
PED 
(n=35)
Overall
(n=346)
Expectant 
observation
140 (49)  8 (25) 20 (57) 168 (48) 136 (49)      9 (28)    17 (49) 162 (47) 132 (47) 8 (25) 16 (46) 156 (45)
Antibiotics 200 (71) 28 (88) 20 (57) 248 (71) 147 (52) 21 (66) 16 (46) 184 (53) 170 (61) 27 (84) 20 (57) 217 (63)
Corticosteroids 85 (30) 14 (44) 8 (23) 107 (31) 73 (26) 12 (37)  7 (20)   92 (27) 95 (34) 14 (44) 11 (31) 120 (35)
Acetaminophen  217 (77) 19 (59) 31 (89) 267 (76) 151 (54) 12 (37) 22 (63) 185 (53) 128 (46) 13 (41) 18 (51) 159 (46)
Ibuprofen 49 (17)  9 (28) 8 (23) 66 (19) 74 (26) 11 (34)  9 (26)   94 (27) 78 (28) 9 (28) 13 (37) 100 (29)
Decongestant/
antihistamine
201 (71) 29 (91) 24 (69) 254 (73) 222 (79) 30 (94) 29 (83) 281 (81) 145 (52) 29 (91) 21 (60) 195 (56)
Topical antibiotics 71 (25) 2 (6) 7 (20) 80 (23) 69 (25) 2 (6) 6 (17)   77 (22) 73 (26) 2 (6) 11 (31) 86 (25)
Topical analgesics 32 (11) 0 (0) 4 (11) 36 (10) 33 (12) 1 (3)     3 (9)   37 (11) 41 (15) 1 (3) 5 (14) 47 (14)
Physiotherapy   18 (6) 2 (6)     2 (6)  22 (6)    19 (7) 1 (3) 4 (11) 24 (7)    17 (6) 1 (3)     1 (3)  19 (6)
*Clinicians may choose more than one treatment option
(44%) would prescribe corticosteroids when compared 
to other specialties (general practitioners 30%; 
pediatricians 23%). In the second scenario, 66% of 
ENT specialists would prescribe antibiotics, followed 
by general practitioners (52%) and pediatricians 
(46%). Thirty-seven per cent of ENT specialists and 
only up to quarter of general practitioners (26%) and 
pediatricians (20%) would choose corticosteroids. 
In the third scenario, 84% of ENT specialists would 
prescribe antibiotics for AOM, followed by general 
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practitioners (61%) and pediatricians (57%). 
Corticosteroids were more likely to be prescribed by 
ENT specialists (44%) compared to other specialties 
(general practitioners 34%, pediatricians 31%). 
Clinicians would mostly prescribe acetaminophen 
(59-89%), decongestant/antihistamine (69-91%), and 
antibiotics (57-88%) for a young child with mild AOM 
(Scenario 1) compared with other treatment (e.g., 
ibuprofen, corticosteroids, topical antibiotics, or topical 
analgesics). From all clinical scenarios, ENT specialists 
were more likely to prescribe corticosteroids (37-44%) 
and were less likely to choose expectant observation 
(25-28%), whereas pediatricians (46-57%) followed 
by general practitioners (47-49%) were more likely 
to choose expectant observation compared to ENT 
specialists. However, as clinicians may choose more 
than one treatment for the clinical scenario section, 
there were respondents who chose both expectant 
observation and antibiotics, which by definition 
should be mutually exclusive. By identifying those who 
solely chose expectant observation by withholding 
antibiotic treatment, pediatricians (43-54%) were 
still more likely to choose expectant observation 
compared to other specialties in all three scenarios. 
The rate of corticosteroid prescribed by pediatricians 
and general practitioners ranged from 20% to 34% 
across the three scenarios. A significant difference 
between specialty groups was identified in the first 
scenario, where pediatricians were significantly less 
likely to prescribe antibiotics (P=0.024) compared to 
general practitioners and ENT specialists, and in the 
third scenario where ENT specialists were more likely 
to prescribe antibiotics (P=0.026) compared to other 
specialties. With regards to prescribing antibiotics in 
each scenario among these specialties, ENT specialists 
were more likely to prescribe antibiotics compared 
to other specialties, particularly in the first and third 
scenarios.
As shown in Figure 1, of the 352 clinicians 
from Jakarta, Depok, and Bekasi, 171 respondents 
(49%) indicated their willingness to participate in 
our proposed clinical trial testing corticosteroids 
as an alternative treatment for AOM in children. 
Their characteristics were similar to the whole survey 
sample. They managed 443 children with AOM in 
a week. Most clinicians had less than three cases of 
AOM during this period (75%), with most of these 
children aged older than five years. ENT specialists 
had more AOM cases (three to five cases) per week 
compared to other specialties. These clinicians had 
a similar practice in the management of AOM and 
responses to clinical scenarios to the whole sample. 
Up to 44% of clinicians, mostly ENT specialists, would 
consider using corticosteroids in a trial.
Discussion
Our sample of clinicians who worked in Jakarta, Depok, 
and Bekasi, reported that they mostly diagnosed AOM 
by using an otoscope. Most general practitioners 
would prescribe amoxicillin for a short duration (3-5 
days), whilst ENT specialists and pediatricians were 
more likely to prescribe amoxicillin-clavulanate for 
a longer duration. Clinical scenario results showed 
there was a high rate of antibiotics prescribed for mild 
AOM. Up to 44% of clinicians would have prescribed 
corticosteroids for children with AOM. Both 
corticosteroids and antibiotics were mostly prescribed 
by ENT specialists in the scenarios. There is no clear 
justification for a high rate of antibiotic prescribing 
by ENT specialists. As ENT specialists saw more 
patients with AOM in the sampled week compared 
to other specialties, their contribution to antibiotic 
prescribing would be higher and, therefore, the risks 
correlated with antibiotic use, such as adverse events 
and antibiotic resistance would be increased.5,9,10 
Another reason for this high use was due to potential 
complications following AOM, such as spontaneous 
perforation of the tympanic membrane (15%) and 
persistent middle ear effusion (25%).17,18 High rates 
of antibiotic prescribing by general practitioners might 
be influenced by the Indonesian practice guideline 
recommending antibiotics for both mild and severe 
AOM.7 Interestingly, we found pediatricians were 
less likely to prescribe antibiotics for all scenarios in 
the study. One potential justification for this was that 
international pediatrics practice guidelines do not 
recommend antibiotics for common colds and only 
recommend antibiotics for AOM with high risks (e.g., 
children with severe signs and symptoms, children < 
2 years with bilateral AOM, or tympanic membrane 
perforation).3,4,19 Corticosteroids and antibiotics were 
more likely to be prescribed for AOM in younger 
children and recurrent bilateral AOM. These are 
not entirely in accordance with the guidelines, as 
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corticosteroids have not been recommended by any 
guidelines. The guidelines only recommend the use 
of antibiotics for children under two years of age 
with bilateral AOM, whilst our scenario was a case 
of unilateral AOM.3 
Unfortunately, few clinicians (<7%, and none 
of the ENT specialists) used pneumatic otoscopy, 
which enables the assessment of tympanic membrane 
mobility.3,20 A systematic review showed that a 
pneumatic otoscope performed by a skilled clinician 
can accurately diagnose AOM with high predictive 
values. It can replace tympanometry as one diagnostic 
tool for AOM, as the pneumatic otoscope is a more 
affordable.21 Our clinical scenarios demonstrated 
that most clinicians would prescribe antibiotics over 
expectant observation for mild AOM. Evidence 
recommends expectant observation with sufficient 
pain management for mild AOM.3-5,9 Only 30% 
of AOM cases are severe and require antibiotic 
treatment.5,9 However, antibiotic prescribing rates for 
AOM in developed and developing countries are still 
relatively high. In terms of data from general practices 
in Australia over five years, 89% of new AOM cases 
were managed with antibiotics.22 Meanwhile, data 
from the National Ambulatory Medical Care Survey 
(NAMCS) demonstrated 83.1% of children with 
isolated AOM were managed with antibiotics.23 Our 
study demonstrated that up to 88% of clinicians would 
prescribe antibiotics for a mild case of AOM. The 
Indonesian Practice Guideline recommends antibiotics 
for both mild and severe AOM, which may influence 
the high rate of antibiotic prescribing for AOM in 
Indonesia.7 A red and bulging tympanic membrane 
could be the other reason for antibiotic treatment 
in all scenarios. However, the sign of red tympanic 
membrane is not sensitive (18%), with a low likelihood 
ratio for a positive result of 1.1, regardless of its high 
specificity (84%). Although a bulging tympanic 
membrane will help make the diagnosis, it requires the 
combination of cloudiness and the impaired mobility 
of the tympanic membrane to robustly diagnose 
AOM.20  
Recurrent AOM was the second most common 
reason for antibiotic prescribing in this study. This 
is defined as “the occurrence of 3 or more episodes 
of AOM in a 6-month period or the occurrence of 
4 or more episodes of AOM in a 12-month period 
that includes at least 1 episode in the preceding 6 
months”.3 The American Academy of Pediatrics Clinical 
Practice Guideline does not recommend the use of 
prophylactic antibiotics for reducing the number of 
episodes of AOM in recurrent AOM cases, and yet 
tympanostomy tubes should be offered.3 Systematic 
reviews showed that recurrent AOM is not included 
as one indicator for antibiotic treatment in the 
management of AOM.5,9 However, The 2014 New 
South Wales Guideline  includes recurrent AOM into 
the high-risk middle ear infection category, which 
requires immediate antibiotic treatment. 24
The high rate of antibiotic prescribing in AOM 
indicates the need for alternative non-antibiotic 
treatment for AOM. We propose to test corticosteroids 
for AOM.  Inflammation has been indicated as 
an important mechanism in AOM, despite the 
complexity of the pathophysiology of AOM. This 
involves both cellular and chemical mediators (e.g., 
cytokines, chemokines, mast cells, and leukotrienes). 
Corticosteroids could act as an anti-inflammatory 
agent, particularly in the middle ear,12 and therefore 
reduce pain. Insufficient evidence of the effects of 
corticosteroids for AOM requires a large, high-quality, 
clinical trial to evaluate corticosteroid efficacy to 
improve the resolution of AOM, as a monotherapy 
in mild cases or as an addition to antibiotic therapy 
in severe cases.12
Our feasibility survey demonstrated that there 
were 171 clinicians who were willing to participate 
in our clinical trial and who saw 443 children with 
AOM in a week. They also had similar practices in 
the management of AOM and responses to clinical 
scenarios to the whole sample. This study also 
demonstrated that a sufficient number of clinicians 
would consider using corticosteroids for AOM. This 
finding was surprising; however, this high rate could be 
primed by clinicians’ knowledge of the nature of the 
upcoming clinical trial, which had been provided in 
the consent form and at the conference presentations 
prior to the completion of the questionnaires. As nearly 
half of the clinicians were interested in participating 
in our trial, it is feasible to conduct a clinical trial on 
corticosteroids for AOM in children in Indonesia, 
according to the pre-specified timeline (12 months, 
including a three-month follow-up).
We believe this the first survey of current 
practices of clinicians in the management of pediatric 
AOM in Indonesia, which was the strength of this 
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study. We identified clinicians’ preferred treatment 
options, particularly in choosing corticosteroids, 
expectant observation, and antibiotics. However, this 
study also had several limitations, including the low 
response rate, unclear definition of ‘observation for 
48 to 72 hours’ as one answer option in the clinical 
scenario, and a narrow study-site coverage. We tried 
several recruitment strategies to increase the response 
rate, however, as participation was voluntary, it was 
the respondents’ decision to consent and participate 
in this survey study. There is no gold standard for an 
acceptable minimum survey response rate, however, a 
response rate of at least 70% is desirable.25 Nonetheless, 
surveys involving voluntary clinicians mostly have 
low response rates (< 30%).25 There are several 
factors that influence the willingness of clinicians to 
participate in a survey study, such as concerns about 
disruption of their practice, time, and relevance of the 
survey topic.26 A review assessing survey response rates 
of general practitioners from published primary care 
journals demonstrated that the mean response rate 
was 61% (95% confidence interval 59% to 63%).27 
A cross-sectional study comparing the response 
rates between postal and online survey of general 
practitioners across Australia showed low response 
rates for both (12.4% and < 0.1%, respectively), 
which were similar to our study.28 Several contributing 
factors were workload of the general practitioners, 
increasing number of other similar surveys, and no 
incentives for participating general practitioners. A 
systematic review identifying strategies to improve 
response rates on postal and electronic questionnaires 
demonstrated that the responses were likely almost 
doubled when there were monetary/non-monetary 
incentives, recorded delivery, shorter questionnaires, 
and interesting survey topics.29 We did not have 
any funding to provide incentives. Other weakness 
of the study was Wwe did not clearly define the 
answer option of ‘observation for 48 to 72 hours’ in 
the clinical scenarios. The option for observation for 
48 to 72 hours was meant for clinicians who would 
choose to closely observe the AOM patients without 
antibiotics treatment for 48 to 72 hours. Without 
a clear definition, clinicians who would prescribe 
antibiotics, may also choose observation to see the 
effect of antibiotics. This would limit us to precisely 
identify the proportion of clinicians who would 
solely choose observation by withholding antibiotic 
treatment. As the last study weakness, this study 
only covered three adjacent cities in two provinces 
(Jakarta and a small part of West Java), which certainly 
does not represent the current management practice 
of AOM in Indonesia in general (total provinces in 
Indonesia is 34). To generalize these findings to the 
rest of Indonesia requires a national scale study that 
includes multiple cities (rural and urban) representing 
each province in Indonesia, supported by the Ministry 
of Health, Republic of Indonesia. Given that the self-
reported nature of our study is a further limitation, a 
national study should collect objective data on the 
actual number of AOM cases (including diagnosis 
and treatment) from primary care or hospital patient 
databases. However, our purpose was to survey likely 
practice and participation in a proposed trial.
There is still a high rate of antibiotic prescribing 
among Indonesian clinicians for children with 
AOM. Although it has not been recommended 
in the guidelines, clinicians would consider using 
corticosteroids for AOM. Given nearly half of 
clinicians were interested in participating in a 
future trial on corticosteroids, our proposed trial is 
feasible. This survey demonstrated existing gaps in 
the management of AOM between clinical practice 
and evidence. It is crucial to translate scientific 
evidence to clinical practice to improve the quality 
of the AOM management in children, particularly in 
Indonesia, by promoting an accurate and affordable 
diagnostic tool for AOM, such as a pneumatic 
otoscope, as well as by prescribing antibiotics only 
for severe AOM, and offering an observation under 
adequate pain management for mild cases. Therefore, 
further investigation is required to identify other 
contributing factors to be able to tackle this problem 
comprehensively. 
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